I recently attended the 40th reunion, if I remember

New Post Public Reply Private Reply Replies (0) Message Board
GaryM Moon bound #9901
483
I recently attended the 40th reunion, if I remember correctly, of the bone marrow recipients at City of Hope. It happened to fall almost exactly 2 years after my transplant.

I bring this because if it had been up to Congress, I don't know if it would have been possible. Why? Because it's really the stem cells in the marrow that made it work, and we all know how politics prevented stem cell development for years.

I really don't know if even today researchers are free to work with embryonic stem cells, but fortunately in most applications adult stem cells work, and it was stem cells, not marrow that I received.

I bring this up because I believe this has definite parallels to where things stand on cannabis. While other nations have openly endorsed the use of cannabis in at least limited way, we as a nation go kicking and screaming into the future.

The good news is that in Stem Cells, I believe we've become world leaders in spite of our late adoption of the technology, and in time I believe the same could apply to the beneficial use of cannabis.

That said, I believe that tremendous success is possible without U.S. sales at all for OWCP, as well as other products being developed by other companies. In drugs, last I saw statistics, the U.S. represented 35% of revenue from drug sales, yet we only represent something like 5% of the world population. I suspect if you really want to look at why our healthcare costs are so high, this might be a good place to start.

In my mind, cannabis based products may cut our use of certain other drugs, but on the other hand, it may supplement others and actually increase their sales. I would suspect that Big Pharma is telling our Congressmen not to issue blanket approval for cannabis, but they know the American people won't stand up for banning it where it's already legal. Big Pharma is one of the biggest contributor's to Congress, so it's hard to say when they'll act for the people, instead of their pocketbook, but i think it will happen before all 50 States make it legal.

The FDA in the mean time doesn't really prevent cannabis based products from reaching the market as long as they don't require drug approval. Products essentially derived naturally only need to be shown to be safe, however, if a company want's its products paid for by insurance companies, the best course is by gaining FDA drug approval. That said, we've also heard about courts ordering insurance companies to pay for certain cannabis based products, and I suspect that in time both our cream and sublingual tablets could get such rulings.

I believe that the V.A. might be the key to acceptance of our sublingual tablet for PTSD as they appear to already be open to smoking marijuana in some cases. I believe the sublingual tablet will become a preferable method of administering cannabis, and may get V.A. support well before FDA acceptance as a drug has been established.

Gary

OWC Pharmaceutical Research Corp. (OWCP) Stock Research Links

OWCP Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

CVRx Lawsuit Puts a Hard Date on Investor Decisions

Updated Category News Views 0

One ugly filing after the bell can vaporize years of shareholder confidence, and CVRx just supplied the painful exhibit. On August 7, 2026, shares of CVRx fell $3.55, or 59.76%, to close at $2.39 after the company disclosed a U.S. Department of Justice civil investigative demand in its August 6 Form 10-Q. That is not a routine bad quarter. It is the sort of disclosure...

Continue Reading
MTI Adds Aviation Veterans as Acorn Builds MRO Plan

Updated Category News Views 95

Two old hands entering a boardroom can matter more than another glossy growth slogan, especially in aircraft maintenance, where a delayed part can ground an airplane and turn a customer relationship sour in a hurry. MTI Aviation has added Tony DiSimone Sr. and Aviv Tzur to its board, a move announced November 20, 2026, after Acorn Capital Management took a majority...

Continue Reading
Africa Tech Festival Puts Trust Ahead of AI Hype Cycle

Updated Category News Views 11

Fifteen thousand people can fill a convention centre, but they cannot magically deliver a package, fund a small business, or repair harm from a bad automated decision. That rather useful dose of reality ran through the final day of Africa Tech Festival 2026 in Cape Town. The 29th edition drew more than 15,000 delegates across three days, and the strongest message was not...

Continue Reading
Home Nursing Plans Need Clarity Before the Next Crisis

Updated Category News Views 61

A medication change scribbled on a loose sheet can become a very long night. That is the unglamorous truth behind the discussion from Michael and Marsha Reda of Aurora Home Care in Williamsville, New York: long-term home nursing care depends on a plan people can actually follow when the household is tired, worried, and juggling too much. Their perspective, featured by...

Continue Reading
Hope Charities Makes Care Funding Easier to Track Online

Updated Category News Views 72

A treatment bill can wreck a household long before a diagnosis does. That is the uncomfortable reality behind Hope Charities' new Access to Care website, a centralized resource meant to show people in the bleeding disorders community when diagnosis-specific charitable assistance funds are available. This is not flashy technology, nor should it be treated like some grand...

Continue Reading
GreenTree Faces Softer Rooms, Debt and NYSE Deadline

Updated Category News Views 18

A hotel operator can post positive earnings and still leave shareholders with a nasty headache, and GreenTree's third quarter is that kind of report. NYSE:GHG produced RMB243.0 million in revenue, down 22.2% from a year earlier, while net income slipped to RMB49.3 million from RMB59.0 million. This was not a one-line stumble. Room pricing, occupancy, franchise economics...

Continue Reading
New York Gala Puts $3 Million Behind EB Research Work

Updated Category News Views 0

Three million dollars changes the temperature in a research room, even if it does not magically solve the hard part. EB Research Partnership said its New York gala raised more than $3 million, with Eddie Vedder, Hozier, Tom Holland and Colin Farrell among the names helping draw attention. For a nonprofit operating around research, that is not a fluffy society-page...

Continue Reading
BBW Lawsuit Puts Guidance and Walmart Claims Under Lens

Updated Category News Views 65

A three-month slice of 2026 has landed Build-A-Bear in the sort of mess investors hate most: a securities complaint centered on whether management's upbeat messaging had already outrun the facts. The lawsuit targets purchases of BBW shares from May 28, 2026 through August 26, 2026, alleging violations of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and...

Continue Reading
SDG&E's 21-Year Reliability Run Has Real Investor Weight

Updated Category News Views 66

Seventy minutes without power in a year is the sort of number most people ignore until their refrigerator quits humming. For San Diego Gas & Electric customers, though, it is a meaningful operating result: roughly 70 minutes annually from unplanned outages, on average, over the past decade, alongside fewer than one sustained outage per customer each year. SDG&E has also...

Continue Reading
Midea’s SC26 Cooling Pitch Targets AI Build Delays

Updated Category News Views 49

Heat is the uninvited partner in every AI build, and Midea is making a sensible argument that nobody gets paid for racks sitting idle while piping crews wrestle with a complicated cooling plant. At SC26 in Chicago, held November 17 through 19, the company made its North American debut for a modular prefabricated AI data-center cooling setup built around a magnetic coolant...

Continue Reading

Top 5 Most Recently Viewed Articles

Context Labs Launches Innovative Open-Source Emissions Project

Updated Category News Views 204

Context Labs Introduces a Revolutionary Open Decarbonization Project Context Labs is set to make a significant impact in the world of emissions measurement with the launch of its Open Decarbonization Project (ODP). This initiative, in collaboration with key industry players, aims to foster transparency and reliability in carbon and methane emissions reporting using...

Continue Reading
BioAge Labs Exciting Participation in Key Investor Conferences

Updated Category News Views 124

BioAge Labs' Upcoming Investor Conferences BioAge Labs, Inc. (NASDAQ: BIOA), a dynamic player in the biotechnology sector, is ready to take significant strides in the world of investment discussions. This clinical-stage firm specializes in developing therapeutic products targeting metabolic diseases, particularly by exploring the biology of human aging. Engagements at...

Continue Reading
Tiba Biotech’s Revolutionary Vaccine Against Foot-and-Mouth Disease

Updated Category News Views 322

Introduction to Tiba Biotech's Innovative Vaccine Tiba Biotech is at the forefront of changing the landscape of animal health with its novel vaccine specifically designed to combat Foot and Mouth Disease (FMD). This innovative solution has emerged from an extensive challenge study evaluating its effectiveness in cattle, demonstrating that all vaccinated subjects...

Continue Reading
Santhera Pharmaceuticals Secures NICE Clearance for AGAMREE

Updated Category News Views 144

Santhera's Exciting New Journey with AGAMREE® Santhera Pharmaceuticals is making significant strides in the pharmaceutical industry with its innovative medication AGAMREE® (vamorolone), aimed at providing new hope for those affected by Duchenne muscular dystrophy (DMD). With the recent positive guidance from the National Institute for Health and Care Excellence (NICE),...

Continue Reading
Truelink Capital Invests in Horwitz MEP Expansion

Updated Category News Views 57

Truelink Forges New Path with Horwitz Partnership Private equity news always has a way of stirring the pot, and Truelink Capital's latest move is no exception. They announced a significant investment in Horwitz, a Minneapolis-based firm that's been dealing with mechanical, electrical, and plumbing (MEP) services for what seems like a century. Now, they’re digging in...

Continue Reading